Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minjing Zhang

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 2009
Expression and Purification of glutathione transferase-small ubiquitin-related modifier-metallothionein fusion protein and its neuronal and hepatic protection against D-galactose-induced oxidative damage in mouse modelYadong Huang, Zhijian Su, Yanmei Li, et al.
Renal Failure|April 15, 2025
Dihydromyricetin protects against cisplatin-induced renal injury and mitochondria-mediated apoptosis via the EGFR/HSP27/STAT3 signaling pathwayZheming Xu, Minjing Zhang, Xue Zhang, et al.
Drug Design, Development and Therapy|December 31, 2014
Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal studyJunhui Su, Cui Chang, Qi Xiang, et al.
European Journal of Pharmacology|January 26, 2026
TGR5 rescues renal ischemia-reperfusion injury by suppressing ferroptosis and cAMP/PKA/Nrf2 axisSuhan Zhou, Honghong Wang, Huanhuan Zhu, et al.
Medical Oncology (Northwood, London, England)|November 25, 2025
Scutellarin triggers ferroptosis in ovarian cancer cells via inhibiting AKT/mTOR and JAK2/STAT3 pathwaysSiyi Wang, Minjing Zhang, Chao Tang, et al.
Toxicology and Applied Pharmacology|June 16, 2023
Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosisZheming Xu, Minjing Zhang, Wenwen Wang, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Pharmacology and Experimental Therapeutics|February 12, 2009
Expression and Purification of glutathione transferase-small ubiquitin-related modifier-metallothionein fusion protein and its neuronal and hepatic protection against D-galactose-induced oxidative damage in mouse modelYadong Huang, Zhijian Su, Yanmei Li, et al.
Renal Failure|April 15, 2025
Dihydromyricetin protects against cisplatin-induced renal injury and mitochondria-mediated apoptosis via the EGFR/HSP27/STAT3 signaling pathwayZheming Xu, Minjing Zhang, Xue Zhang, et al.
Drug Design, Development and Therapy|December 31, 2014
Xyloketal B, a marine compound, acts on a network of molecular proteins and regulates the activity and expression of rat cytochrome P450 3a: a bioinformatic and animal studyJunhui Su, Cui Chang, Qi Xiang, et al.
European Journal of Pharmacology|January 26, 2026
TGR5 rescues renal ischemia-reperfusion injury by suppressing ferroptosis and cAMP/PKA/Nrf2 axisSuhan Zhou, Honghong Wang, Huanhuan Zhu, et al.
Medical Oncology (Northwood, London, England)|November 25, 2025
Scutellarin triggers ferroptosis in ovarian cancer cells via inhibiting AKT/mTOR and JAK2/STAT3 pathwaysSiyi Wang, Minjing Zhang, Chao Tang, et al.
Toxicology and Applied Pharmacology|June 16, 2023
Dihydromyricetin attenuates cisplatin-induced acute kidney injury by reducing oxidative stress, inflammation and ferroptosisZheming Xu, Minjing Zhang, Wenwen Wang, et al.
Pageof 2